Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Leishmaniasis, Visceral

• LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study
• A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis
• Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
• Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
• Short Course Regimens for Treatment of PKDL (Sudan)
• Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
• Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
• Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
• Miltefosine for Children With PKDL
• Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
• Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan
• A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
• Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
• SCH708980 With and Without AmBisome for Visceral Leishmaniasis
• Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
• An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
• Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
• A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh
• Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
• Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
• A Community Trial for Visceral Leishmaniasis (VL)
• Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
• Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
• To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
• Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
• Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
• An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
• Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
• Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
• Combination Therapy in Indian Visceral Leishmaniasis
• A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
• A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.
• Miltefosine for Brazilian Visceral Leishmaniasis
• Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
• Combination Chemotherapy for the Treatment of Indian Kala-Azar
• Amphotericin B Treatment in Visceral Leishmaniasis
• Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
• Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis